MSCA and EMBO are two independent postdoctoral fellowship programmes, not one joint award. As verified on 11 November 2026, the 2026 MSCA Postdoctoral Fellowships call is closed; MSCA 2027 is planned for 7 April–8 September 2027. EMBO accepts applications throughout the year, with the next hard evaluation cutoff on 22 January 2027 at 14:00 CET. This guide compares eligibility, first-author research requirements, international mobility, host restrictions, funding, duration and the correct application route for molecular biologists and other life-sciences researchers.
MSCA vs EMBO Postdoctoral Fellowships: Side-by-Side Comparison
| Requirement | MSCA Postdoctoral Fellowships | EMBO Postdoctoral Fellowships |
|---|---|---|
| Current status | 2026 closed; 2027 upcoming | Applications accepted year-round, with spring/autumn evaluations |
| Next cutoff/deadline | 8 September 2027, 17:00 CEST (planned) | 22 January 2027, 14:00 CET (hard cutoff) |
| Research scope | Research in all disciplines | Life sciences, with a relevant biological research question |
| Doctoral timing | Successfully defended by deadline; typically no more than 8 counted post-PhD research years | PhD/equivalent required by fellowship start; if awarded already, generally within 2 years before application |
| First-author research output | No universal mandatory first-author publication | At least one qualifying first-author published/accepted research paper or independently refereed first-author preprint |
| Nationality | European PF: all nationalities; Global PF: eligible EU/associated-country nationals or long-term residents | International candidates subject to EMBO country-move and host rules |
| Mobility | Generally no more than 12 months in relevant host country over previous 36 months | Country move required, plus restrictions involving PhD country, earlier host, supervisor and research continuity |
| Duration | European PF 12–24 months; Global PF 12–24 outgoing + 12 return | Usually 24 months; shorter requests down to 12 months permitted |
| Funding | EU researcher-month units and separate institutional costs | Host employment-contract funding in EMBC countries; stipends outside those member states |
| Submission | Developed jointly; eligible host submits through EU portal | Researcher submits in EMBO system with host acceptance and two references |
| Assessment | Excellence, impact, implementation under the MSCA call | EMBO scientific prescreening, expert interviews and committee selection |
Interpretation: A recent-PhD life scientist with a qualifying first-author output may investigate both schemes. A researcher three or more years beyond PhD award could remain eligible for MSCA yet fall outside EMBO’s ordinary two-year window. These are screening observations, not individual eligibility decisions.
MSCA 2027 Deadline and EMBO’s Year-Round Cutoff System
| Milestone | Verified status or date |
|---|---|
| MSCA PF 2026 close | 9 September 2026 — past |
| MSCA PF 2027 opening | 7 April 2027, provisional |
| MSCA PF 2027 deadline | 8 September 2027, 17:00 CEST, provisional |
| MSCA PF 2027 results | February 2028, indicative |
| EMBO applications | Accepted throughout the year |
| Next EMBO spring cutoff | Friday 22 January 2027, 14:00 CET — hard deadline |
| EMBO autumn evaluation | Normally second Friday of July at 14:00 CEST; verify the exact future date |
EMBO is not rolling assessment: The programme accepts applications year-round, but fully completed submissions enter spring or autumn evaluation rounds. Only a complete application confirmed as submitted before the cutoff enters that round; creating an account alone does not qualify. EMBO normally announces spring results around mid-June and autumn results around mid-December.
The MSCA 2027 call page lists provisional dates; check the live EU Funding & Tenders topic when the call opens. The EMBO application page governs the hard cutoff.
Research Experience and First-Author Publication Rules
MSCA: eight years of counted research experience
MSCA applicants must have successfully defended their doctorate by the call deadline; a final certificate may be pending. They generally need no more than eight years of full-time-equivalent research experience after the PhD award. Time outside research, eligible career breaks and certain research undertaken outside the EU/associated-country area by qualifying researchers returning to Europe can be excluded. The specific exclusions require supporting evidence and the official calculation guidance.
MSCA does not prescribe a universal first-author publication minimum. Previous achievements still matter to scientific evaluation, and the research, training and impact plans must satisfy the call.
EMBO: two-year PhD window and first-author research output
For EMBO, a PhD or equivalent is required at fellowship commencement, but a current doctoral candidate may submit before formal award. If a doctorate has already been awarded, the applicant ordinarily must apply within the following two years. Extraordinary personal-circumstance exceptions may be granted only after approval from the EMBO Fellowships Office; voluntary career breaks do not qualify automatically.
At the time of application, EMBO requires at least one first-author research article accepted/published in an international peer-reviewed journal, or a first-author research preprint that has received publicly available, substantive independent peer review through an appropriate service. An ordinary unreviewed preprint does not satisfy the rule.
EMBO also excludes direct continuations of the PhD research project. The proposal should establish a meaningful new scientific direction and the value of the proposed host.
Choosing an Eligible Host: International Mobility Rules Differ
| Situation | MSCA | EMBO |
|---|---|---|
| Recent activity in relevant host country | Normally at most 12 months over 36 months before the call deadline, with specified exceptions | International relocation required; applicant already at proposed host can apply only when living there less than six months at application |
| Returning to country where PhD was obtained | Not universally excluded; country residence/activity history controls | Excluded |
| Returning to an earlier host laboratory | Check country mobility and beneficiary rules | Not eligible if previously worked at host for more than six months |
| Returning to PhD department, institute or supervisor | Check host/mobility and scientific eligibility | Excluded, including returning to the PhD supervisor in another country |
| Eligible host type | EU Member State/Horizon Europe associated-country beneficiary; Global PF includes international outgoing partner | Appropriate eligible receiving laboratory and country under EMBO mobility rules |
Host-selection check: Before drafting, assess past country residence, previous laboratory appointments, PhD supervisor relationships, scientific facilities and the host’s ability to employ or accommodate the fellow. For EMBO, confirm that the laboratory has not committed its one applicant place in the relevant selection round.
Funding and Benefits: MSCA EU Contributions Are Not EMBO Salaries
MSCA: country-corrected funding units
Under the current 2026–27 MSCA framework, the EU living-allowance contribution is €6,350 per researcher-month, with €710 mobility and €660 conditional family allowance. These are not universal net pay amounts. Country correction coefficients, employer costs, social-security obligations and taxes affect the researcher’s actual contract; other separate unit contributions support research, training, networking and administration.
European PFs last 12–24 months. Global PFs entail 12–24 months outside the eligible European area plus a mandatory 12-month return phase. Certain projects can include additional, rule-bound non-academic placement time.
EMBO: host-specific contract or stipend
EMBO Fellowships are usually awarded for two years, with a permitted minimum request of one year. In EMBC member states, EMBO makes a grant to the host so it can issue an employment contract; in other eligible host countries, the fellow receives a stipend. Rates depend on destination and applicable programme rules, so no single EMBO monthly amount applies worldwide.
EMBO provides qualifying travel/relocation support, professional-development and networking opportunities, and conditional childcare-related support. Its funding does not cover bench fees, consumables or institutional overheads, so the receiving laboratory must confirm those arrangements separately.
Required Application Documents and Official Submission Routes
| Stage | MSCA PF 2027 | EMBO PF |
|---|---|---|
| Application system | EU Funding & Tenders Portal | EMBO online system |
| Who submits? | Eligible beneficiary submits proposal prepared jointly with researcher | Researcher submits completed EMBO application and confirms completion |
| Main scientific content | Call-specific research, methodology, training, impact and implementation proposal | Biological research question, previous scientific achievements and significance, host choice and scientific development |
| Supporting documentation | Live 2027 applicant guide, administrative forms, budget and supporting annexes when published | Two references and receiving-institute acceptance plus required project and researcher information |
| Publication evidence | Research record relevant to scientific evaluation; no fixed first-author threshold | Eligible first-author paper or independently refereed first-author preprint |
| Final submission test | Portal validation and official 2027 deadline | Applicant confirms the complete submission before the hard selection-round cutoff |
- Screen eligibility: Verify doctorate date, counted experience, first-author output, nationality and host-country/mobility history.
- Agree a qualifying host: Confirm relevant supervisor, facilities, appointment type, support and EMBO one-candidate-per-round capacity if applicable.
- Prepare the specific scientific case: For MSCA, explain excellence, training, career impact and implementation; for EMBO, explain new biological insight, prior achievements and scientific value of moving hosts.
- Gather required records: Use the current official instructions and arrange EMBO references/host acceptance in advance; use the final 2027 MSCA forms after the call opens.
- Submit in the correct system: Do not confuse EU host-led submission with the EMBO applicant portal, and do not treat account registration as a completed application.
Evaluation and Reapplication Restrictions
MSCA evaluation
MSCA PF is reviewed competitively under excellence, impact and implementation. A restriction on 2027 resubmissions may apply when the same researcher and beneficiary were involved in an immediately preceding unsuccessful PF application scoring below 80%; refer to the detailed, call-specific rules rather than assuming all unsuccessful applicants are excluded.
EMBO evaluation and new one-application rule
EMBO verifies eligibility and completeness, then a fellowship committee prescreens candidates based on prior scientific achievements, the biological significance and novelty of the proposed work, and the suitability of the receiving laboratory. Shortlisted applicants normally undergo an expert interview before the committee makes a funding decision.
Host restriction: Since the Autumn 2026 round, a host lab may support only one candidate per selection round. Reapplication restriction: Any EMBO proposal submitted after 22 January 2027 at 14:00 CET falls under the new one-proposal-only, no-reapplication rule. Applicants with an earlier submission or unusual eligibility circumstances should consult EMBO directly before planning a second attempt.
EMBO’s published schedule indicates spring results around mid-June and autumn results around mid-December; individual outcomes may vary. A high-quality proposal is not a guarantee of selection under either programme.
Which Fellowship Should a Molecular Biologist Consider First?
| Candidate profile | Practical programme choice |
|---|---|
| PhD completed in the past two years; qualifying first-author research output; eligible international move | Investigate both MSCA and EMBO, considering their independent mobility and host restrictions |
| PhD awarded more than two years ago, with no recognised exceptional interruption | Check MSCA first; EMBO’s usual PhD-window rule may exclude the researcher |
| No first-author paper or independently refereed first-author preprint | Check MSCA first if otherwise eligible; EMBO first-author output is mandatory |
| Indian researcher seeking a university or institute in an eligible European host country | European MSCA PF and potentially EMBO, subject to their separate country, research and host conditions |
| Researcher with an eligible EU/associated-country nationality or long-term residence seeking non-European experience plus a return year | Explore MSCA Global PF; EMBO is not equivalent to its outgoing-and-return structure |
| Candidate proposing return to PhD country, laboratory or PhD supervisor | EMBO is generally excluded under its host/mobility rules; assess MSCA rules separately |
Frequently Asked Questions
Is there one combined MSCA and EMBO fellowship?
No. MSCA Postdoctoral Fellowships and EMBO Postdoctoral Fellowships are separate programmes with different funders, eligibility rules, submission systems and evaluations.
Can I apply to EMBO in November or December 2026?
Yes. EMBO accepts applications year-round; the next hard spring-round cutoff is 22 January 2027, 14:00 CET. Submit the completed application, not just account registration.
Can I resubmit an EMBO fellowship after rejection?
For applications submitted after 22 January 2027 at 14:00 CET, EMBO’s rule no longer permits reapplication. Earlier submissions should be assessed under the applicable policy with EMBO directly.
Does EMBO accept a preprint instead of a published first-author article?
Only a qualifying first-author research preprint with publicly available, substantive, independently arranged peer review can substitute. An ordinary unreviewed preprint does not qualify.
Can a researcher from India apply for MSCA European or EMBO support?
Indian nationality itself does not exclude applicants from the MSCA European route. EMBO eligibility depends on its participating-country and mobility rules, recent doctorate, first-author research output and eligible host.
Do I need a PhD certificate before submitting?
MSCA accepts successful doctoral defence by the application deadline even if the formal award follows. EMBO permits applications from candidates who will have the required doctorate or equivalent by the fellowship start.
Are MSCA and EMBO monthly funding amounts directly comparable?
No. MSCA publishes EU unit contributions subject to country and employer factors. EMBO provides destination-dependent employment-contract grants or stipends, with different support for expenses. Obtain the actual host offer.
Who submits the proposal?
For MSCA, the qualifying beneficiary submits a joint researcher–host proposal. For EMBO, the researcher completes the EMBO system with two references and receiving-institute acceptance.
Official Sources and Verification
| Scope | Comparison of two separate postdoctoral fellowship programmes |
|---|---|
| MSCA PF 2026 | Closed on 9 September 2026 |
| MSCA PF 2027 | Planned 7 April–8 September 2027 (subject to official call confirmation) |
| EMBO next cutoff | 22 January 2027 at 14:00 CET; year-round submission between evaluation rounds |
| EMBO host limit | One supported candidate per host laboratory per selection round |
| EMBO reapplication rule | No reapplications for submissions after 22 January 2027, 14:00 CET |
| Last verified | 11 November 2026 |
CareerAidHub is not affiliated with EMBO or the European Commission. This comparison distinguishes confirmed rules, provisional future call dates and independent applicant guidance. Eligibility, application acceptance, benefits and awards depend on the original programme and each applicant’s circumstances.
